These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21466496)

  • 1. Thiopurine immunomodulators in ulcerative colitis: moving forward with current evidence.
    La Nauze RJ; Sparrow MP
    Curr Drug Targets; 2011 Sep; 12(10):1406-12. PubMed ID: 21466496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T; Ma C
    Expert Opin Biol Ther; 2020 Apr; 20(4):379-390. PubMed ID: 31874578
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
    Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
    Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of long-term thiopurine maintenance treatment for ulcerative colitis in Turkey: A single-center experience.
    Özgenç F; Karakoyun M; Ecevit Ç; Hekimci H; Kıran Taşçı E; Erdemir G
    Turk J Gastroenterol; 2018 Nov; 29(6):650-654. PubMed ID: 30381272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising use of thiopurines in inflammatory bowel disease.
    Dart RJ; Irving PM
    Expert Rev Clin Immunol; 2017 Sep; 13(9):877-888. PubMed ID: 28678626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive and biologic therapy for ulcerative colitis.
    Ardizzone S; Cassinotti A; de Franchis R
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):449-67. PubMed ID: 23163556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy for ulcerative colitis: the state of the art and beyond.
    Ross AS; Cohen RD
    Curr Gastroenterol Rep; 2004 Dec; 6(6):488-95. PubMed ID: 15527679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for ulcerative colitis.
    Xu CT; Meng SY; Pan BR
    World J Gastroenterol; 2004 Aug; 10(16):2311-7. PubMed ID: 15285010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
    Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important is onset of action in ulcerative colitis therapy?
    Masson S; Nylander D; Mansfield JC
    Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
    Wisch N; Korelitz BI
    Surg Clin North Am; 1972 Aug; 52(4):961-9. PubMed ID: 5047533
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor response to thiopurine in inflammatory bowel disease: how to overcome therapeutic resistance?
    Chouchana L; Roche D; Jian R; Beaune P; Loriot MA
    Clin Chem; 2013 Jul; 59(7):1023-6. PubMed ID: 23813427
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
    Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study.
    Eriksson C; Rundquist S; Cao Y; Montgomery S; Halfvarson J
    Gut; 2019 Apr; 68(4):623-632. PubMed ID: 29618498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy.
    López-Palacios N; Mendoza JL; Taxonera C; Lana R; López-Jamar JM; Díaz-Rubio M
    Eur J Intern Med; 2011 Dec; 22(6):621-5. PubMed ID: 22075292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the management of ulcerative colitis.
    Taba Taba Vakili S; Taher M; Ebrahimi Daryani N
    Acta Med Iran; 2012; 50(6):363-72. PubMed ID: 22837114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.